Clarivate Completes Sale of Life Sciences Segment
Clarivate sold its Life Sciences & Healthcare segment for $600M to Altaris simplifying its portfolio. This transaction advances the company's strategic transformation, strengthens its balance sheet and enhances financial flexibility, with updated guidance expected upon Q3 2026 results.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed